Robert J. Kammer is Director at Imprimis Pharmaceuticals, Inc. (IMMY). They have made 6 open-market trades across 2 companies since 2017, most recently 2019-11-11.
CIK 0001542484
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HROW | SELL · 10b5-1 | 2019-11-11 | 2019-11-13 | $4.75 | $31K | +18.3% | +27.2% | +35.5% |
| HROW | SELL · 10b5-1 | 2019-10-07 | 2019-10-08 | $5.25 | $34K | -1.2% | -5.2% | +33.5% |
| HROW | SELL · 10b5-1 | 2019-09-09 | 2019-09-11 | $5.67 | $37K | -9.9% | -17.8% | +5.3% |
| HROW | SELL · 10b5-1 | 2019-08-12 | 2019-08-14 | $6.89 | $45K | -19.9% | -6.4% | -23.8% |
| HROW | SELL | 2019-07-15 | 2019-07-16 | $7.91 | $51K | -0.4% | -37.6% | -35.5% |
| HROW | SELL | 2019-06-03 | 2019-06-05 | $5.78 | $58K | -1.0% | +33.6% | -16.4% |
| HROW | SELL · 10b5-1 | 2019-05-01 | 2019-05-03 | $4.57 | $46K | +28.8% | +30.9% | +69.4% |
| HROW | SELL · 10b5-1 | 2019-04-01 | 2019-04-02 | $4.77 | $48K | -8.6% | -4.8% | +67.4% |
| HROW | SELL | 2019-03-01 | 2019-03-04 | $6.91 | $69K | -21.2% | -32.8% | -16.2% |
| HROW | SELL | 2019-02-01 | 2019-02-01 | $5.86 | $59K | +0.7% | +13.2% | -25.7% |
| HROW | SELL | 2019-01-02 | 2019-01-03 | $5.33 | $53K | +15.5% | +22.7% | -8.8% |
| IMMY | SELL · 10b5-1 | 2018-12-03 | 2018-12-06 | $4.64 | $46K | +6.6% | N/A | N/A |
| IMMY | SELL · 10b5-1 | 2018-11-01 | 2018-11-02 | $4.21 | $42K | +3.6% | +7.0% | N/A |
| IMMY | SELL · 10b5-1 | 2018-10-15 | 2018-10-18 | $3.00 | $30K | +27.2% | +49.7% | N/A |
| IMMY | SELL · 10b5-1 | 2018-09-04 | 2018-09-05 | $3.00 | $30K | -8.7% | -12.3% | +58.0% |
| IMMY | SELL | 2018-08-10 | 2018-08-15 | $3.00 | $390K | +7.7% | -1.7% | +35.0% |
| IMMY | SELL · 10b5-1 | 2017-07-17 | 2017-07-19 | $3.05 | $31K | -11.6% | -21.2% | -49.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.